Conjunctivitis Among Individuals with Moderate-to-Severe Atopic Dermatitis Treated with Dupilumab in the United States

被引：0
|
作者：
Franklin, Jessica M. [1 ]
Marcus, Andrea F. [2 ]
Sultan, Ihtisham [3 ]
Howell, Ashley [3 ]
Sinnott, Sarah-Jo [4 ]
Green, Jeannette [3 ]
Ezzy, Stephen M. [1 ]
Gately, Robert [1 ]
Sobel, Rachel E. E. [3 ]
Wang, Florence [1 ]
机构：
[1] Optum, Eden Prairie, MN USA
[2] Regeneron Pharmaceut, Tarrytown, NY USA
[3] Regeneron, Tarrytown, NY USA
[4] Sanofi, Paris, France
来源：
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY | 2024年 / 33卷
关键词：
D O I：
暂无
中图分类号：
R1 [预防医学、卫生学];
学科分类号：
1004 ; 120402 ;
摘要：
221
引用
收藏
页码：77 / 78
页数：2
相关论文
共 50 条
  • [31] Effect of abrocitinib and dupilumab on eosinophil levels in patients with moderate-to-severe atopic dermatitis
    Staumont-Salle, Delphine
    Barbarot, Sebastien
    Bouaziz, Jean David
    Chan, Chan
    Clibborn, Claire
    Du-Thanh, Aurelie
    Feeney, Claire
    Lejeune, Alexandre
    Misery, Laurent
    Nosbaum, Audrey
    Seneschal, Julien
    Soria, Angele
    Zhang, Fan
    JEADV CLINICAL PRACTICE, 2023, 2 (03): : 518 - 530
  • [32] Dupilumab improves the molecular signature in skin of patients with moderate-to-severe atopic dermatitis
    Hamilton, Jennifer D.
    Suarez-Farinas, Mayte
    Dhingra, Nikhil
    Cardinale, Irma
    Li, Xuan
    Kostic, Ana
    Ming, Jeffrey E.
    Radin, Allen R.
    Krueger, James G.
    Graham, Neil
    Yancopoulos, George D.
    Pirozzi, Gianluca
    Guttman-Yassky, Emma
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2014, 134 (06) : 1293 - 1300
  • [33] Dupilumab Treatment Rapidly Improves Itch in Patients With Moderate-to-Severe Atopic Dermatitis
    Silverberg, Jonathan I.
    Chao, Jingdong
    Eckert, Laurent
    Chen, Zhen
    Ardeleanu, Marius
    Shumel, Brad
    Plaum, Stefan
    Graham, Neil M. H.
    Pirozzi, Gianluca
    Gadkari, Abhijit
    JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2018, 16 : 29 - 29
  • [34] Predictive Factors of Early Response to Dupilumab in Patients with Moderate-to-Severe Atopic Dermatitis
    Ferrucci, Silvia
    Casazza, Giovanni
    Zussino, Martina
    Tavecchio, Simona
    Marzano, Angelo V.
    Tedeschi, Micol
    JOURNAL OF CLINICAL MEDICINE, 2023, 12 (20)
  • [35] Dupilumab reduces inflammatory biomarkers in pediatric patients with moderate-to-severe atopic dermatitis
    Beck, Lisa A.
    Muraro, Antonella
    Boguniewicz, Mark
    Chen, Zhen
    Zahn, Joseph
    Marco, Ainara Rodriguez
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2025, 155 (01)
  • [36] Efficacy of dupilumab in moderate and severe atopic dermatitis
    Weidinger, Stephan
    Simpson, Eric L.
    Silverberg, Jonathan I.
    Schmitt, Jochen
    Leshem, Yael A.
    Katoh, Norito
    Chen, Zhen
    Zhang, Haixin
    Shumel, Brad
    Bansal, Ashish
    Chao, Jingdong
    Lu, Yufang
    Rossi, Ana B.
    Abramova, Alvina
    JEADV CLINICAL PRACTICE, 2023, 2 (02): : 247 - 260
  • [37] Dupilumab (Dupixent) for Moderate to Severe Atopic Dermatitis
    不详
    MEDICAL LETTER ON DRUGS AND THERAPEUTICS, 2017, 59 (1519): : 64 - 66
  • [38] Lebrikizumab for Moderate-to-Severe Atopic Dermatitis
    Smith, Brandon I.
    Engel, Priya
    Wu, Jashin
    NEW ENGLAND JOURNAL OF MEDICINE, 2023, 388 (24): : 2299 - 2300
  • [39] Switching from dupilumab to abrocitinib in patients with moderate-to-severe atopic dermatitis: an analysis of responders and nonresponders to dupilumab
    Silverberg, Jonathan, I
    Simpson, Eric L.
    Thyssen, Jacob P.
    Pink, Andrew E.
    Weidinger, Stephan
    Chan, Gary
    Lazariciu, Irina
    Clibborn, Claire
    Guler, Erman
    BRITISH JOURNAL OF DERMATOLOGY, 2023, 188
  • [40] LONG-TERM SAFETY IN ADULTS WITH MODERATE-TO-SEVERE ATOPIC DERMATITIS TREATED WITH DUPILUMAB UP TO 4 YEARS
    Blauvelt, A.
    Eichenfield, L.
    Sierka, D.
    Chen, Z.
    Khokhar, F.
    Marco, A. Rodriguez
    Shabbir, A.
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2022, 129 : S19 - S19
12345